CLINICAL_TRIALS
withdrawal
· 2012-11-27
Clinical Trial Update: Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks [Phase 4]
Summary
A Phase 4 clinical trial comparing Nebido to placebo for late-onset hypogonadism in elderly men has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Hypogonadism | Phase 4 | Status: WITHDRAWN